Berk, B.* et al. 270 Impact of topical corticosteroids and pH-modulating emollients on skin physiology and skin microbiome in atopic dermatitis patients. J. Invest. Dermatol. 145, e74 - e74 (2025)
Hübenthal, M.* et al. 292 Role of innate immunity in molecular differentiation and mechanistic validation of endotypes of Atopic Dermatitis. J. Invest. Dermatol. 145, S318 - S318 (2025)
Kurzen, N.* et al. Death-associated protein kinase 1 dampens keratinocyte necroptosis and expression of genes in lichen planus. J. Invest. Dermatol. 145, 1921-1929.e13 (2025)
Scala, E.* et al. 331 IL-34 expression and function in hidradenitis suppurativa and psoriasis. In: (, 10 September 2025, Antwerp). 2025. S324 - S324 (J. Invest. Dermatol. ; 145)
Schneider, M.R.* & Meier, M. Bringing high-resolution spatial order to sebaceous glands. J. Invest. Dermatol., DOI: 10.1016/j.jid.2025.05.010 (2025)
Kurzen, N.* et al. Death associated protein kinase 1 dampens keratinocyte necroptosis and expression of inflammatory genes in lichen planus. J. Invest. Dermatol., DOI: 10.1016/j.jid.2024.11.017 (2024)
Almet, A.A.* et al. A Roadmap for a consensus human skin cell atlas and single-cell data standardization. J. Invest. Dermatol. 143, 1667-1677 (2023)
Filipp, F.V. Spatial cancer systems biology resolves heterotypic interactions and identifies disruption of spatial hierarchy as a pathological driver event. J. Invest. Dermatol. 143, 1342-1347 (2023)
Fischer, F. et al. Gene expression-based molecular test as diagnostic aid for the differential diagnosis of psoriasis and eczema in formalin-fixed and paraffin-embedded tissue, microbiopsies, and tape strips. J. Invest. Dermatol. 143, 1461-1469.e5 (2023)
Correa-Gallegos, D. ; Machens, H.G.* & Rinkevich, Y. States and fates of skin fibroblasts revealed through chromatin accessibility. J. Invest. Dermatol. 142, 1767-1770 (2022)
Rajendran, V. et al. Therapeutic silencing of p120 in fascia fibroblasts ameliorate tissue repair. J. Invest. Dermatol. 143:854-863.e4 (2022)
Seiringer, P. ; Garzorz-Stark, N.* & Eyerich, K.* T-cell‒mediated autoimmunity: Mechanisms and future directions. J. Invest. Dermatol. 142, 804-810 (2022)
Speth, P.* et al. Immunocompromised patients with therapy-refractory chronic skin diseases show reactivation of latent EBV and CMV infection. J. Invest. Dermatol. 142, 549-558.e6 (2022)
Thomas, J. et al. CD23 levels on B cells determine long-term therapeutic response in patients with atopic eczema treated with selective IgE immune apheresis. J. Invest. Dermatol. 141, 681-685.e6 (2021)
Chuah, S.Y.* et al. Volumetric multispectral optoacoustic tomography for 3-dimensional reconstruction of skin tumors: A further evaluation with histopathologic correlation. J. Invest. Dermatol. 139, 481-485 (2019)
Eyerich, K.* & Eyerich, S. Immune response patterns in chronic inflammatory skin diseases a basis of targeted therapy. J. Invest. Dermatol. 138, S16-S16 (2018)
Heppt, M.V.* et al. MSX1-induced neural crest-like reprogramming promotes melanoma progression. J. Invest. Dermatol. 138, 141-149 (2018)
Hiller, J. et al. STAT1 gain-of-function and dominant negative STAT3 mutations impair IL-17 and IL-22 immunity associated with CMC. J. Invest. Dermatol. 138, 711-714 (2018)
Jargosch, M.* et al. Necroptosis as special type of cell death in inflammatory skin diseases. J. Invest. Dermatol. 138, S116-S116 (2018)
Lauffer, F.* et al. Type I immune response induces keratinocyte necroptosis and is associated with interface dermatitis. J. Invest. Dermatol. 138, 1785-1794 (2018)
Schmidt, M.O.* et al. The role of Fibroblast growth factor binding protein 1 in skin carcinogenesis and inflammation. J. Invest. Dermatol. 138, 179-188 (2018)
Buters, J.T.M. & Biedermann, T.* Chromium(VI) contact dermatitis: Getting closer to understanding the underlying mechanisms of toxicity and sensitization! J. Invest. Dermatol. 137, 274-277 (2017)
Fuertes, E.* ; Flohr, C.* ; Silverberg, J.I.* ; Standl, M. & Strachan, D.P.* Global associations between UVR exposure and current eczema prevalence in children from ISAAC Phase Three. J. Invest. Dermatol. 137, 1248-1256 (2017)
Garzorz-Stark, N.* et al. TLR7/8 agonists stimulate plasmacytoid dendritic cells to initiate a Th17-deviated acute contact dermatitis in humans. J. Invest. Dermatol. 137, S275-S275 (2017)
Guttman-Yassky, E.* et al. A pathogenic role for Th22/IL-22 in atopic dermatitis is established by a placebo-controlled trial with an anti IL-22/ILV-094 mAb. J. Invest. Dermatol. 137, S53-S53 (2017)
Hermann, H.* et al. miR-146b probably assists miRNA-146a in the suppression of keratinocyte proliferation and inflammatory responses in psoriasis. J. Invest. Dermatol. 137, 1945-1954 (2017)
Kong, H.H.* et al. Performing skin microbiome research: A method to the madness. J. Invest. Dermatol. 137, 561-568 (2017)
Laemmermann, I.* et al. Blocking negative effects of senescence in human skin fibroblasts with a plant extract. J. Invest. Dermatol. 137, S311-S311 (2017)
Lauffer, F.* et al. Interface Dermatitis is characterized by a type I immune response and an epidermal reaction to IFN-gamma and TNF-alpha. J. Invest. Dermatol. 137, S254-S254 (2017)
Standl, M. et al. Association of atopic dermatitis with cardiovascular risk factors and diseases. J. Invest. Dermatol. 137, 1074-1081 (2017)
Terlecki-Zaniewicz, L.* et al. Senescent human fibroblasts selectively secrete miRNAs in extracellular vesicles and modulate keratinocyte functionality during skin aging. J. Invest. Dermatol. 137, S250-S250 (2017)
Aguirre Bueno, J. et al. Assessment of psoriasis using label-free ultra-broadband optoacoustic mesoscopy. J. Invest. Dermatol. 136, S217-S217 (2016)
Altunbulakli, C.* et al. Transcriptomic analysis of epidermal barrier molecules, cytokines and growth factors in atopic dermatitis lesions. J. Invest. Dermatol. 136, S177-S177 (2016)
Bounas-Pyrros, N. ; Todorova, A. ; Biedermann, T.* ; Hofmann, H.* & Traidl-Hoffmann, C. Establishing and validating a new flow cytometric method for diagnosis of Lyme borreliosis. J. Invest. Dermatol. 136, S232-S232 (2016)
Buters, J.T.M. et al. Differences in the biological exposome between Munich, Germany and Davos, Switzerland. Report of a 4 year period of daily outdoor levels. J. Invest. Dermatol. 136, S235-S235 (2016)
Dietz, K. et al. Age dictates a steroid resistant cascade of wnt5a, transglutaminase-2 and leukotrienes in inflamed airways. J. Invest. Dermatol. 136, S225-S225 (2016)
Dittlein, D.C. ; Gilles, S. ; Frank, U. ; Gross, O.* & Traidl-Hoffmann, C. Pollen and UV-B: A couple modulating human skin barrier and immune function. J. Invest. Dermatol. 136, S220-S220 (2016)
Effner, R. et al. Cytochrome P450s are deactivators of the aryl hydrocarbon receptor in human immune cells. J. Invest. Dermatol. 136, 2, S232-S232 (2016)
Ford, S.J. et al. Structural and functional analysis of intact hair follicles and pilosebaceous units by volumetric multispectral optoacoustic tomography. J. Invest. Dermatol. 136, 753-761 (2016)
Graessel, A. et al. Identification of new cell surface targets on human T helper cells. J. Invest. Dermatol. 136, S232-S232 (2016)
Jakwerth, C.A. et al. Grass pollen-specific immunotherapy entails systemic increase of regulatory B cells and shift in Th17 cell compartments. J. Invest. Dermatol. 136, S225-S225 (2016)
Kuepper, M.K.* et al. Characterization of multiple B cell subsets in peripheral blood of psoriasis patients identifies a correlation of regulatory B cells and disease severity. J. Invest. Dermatol. 136, S217-S217 (2016)
Lauffer, F.* et al. Interface dermatitis shows a distinctive molecular signature independent from individual disease background. J. Invest. Dermatol. 136, S219-S219 (2016)
Lovaszi, M.* et al. Characterization of the immunomodulatory effects of sebocytes on macrophages. J. Invest. Dermatol. 136, S231-S231 (2016)
Manz, J. et al. Targeted resequencing and functional testing identifies low-frequency missense variants in the gene encoding GARP as significant contributors to atopic dermatitis risk. J. Invest. Dermatol. 136, 2380-2386 (2016)
Musiol, S. et al. The Ying & Yang of IL23p40 in psoriatic plaque formation. J. Invest. Dermatol. 136, S261-S261 (2016)
Russkamp, D. et al. Alum-free thermosensitive hydrogel as subcutaneous matrix for immunomodulators and allergens during specific immunotherapy. J. Invest. Dermatol. 136, 2, S231-S231 (2016)
Schlumprecht, C. et al. Immuno-modulatory effects of pre-/probiotics and active microbial structures on human primary keratinocytes. J. Invest. Dermatol. 136, S208-S208 (2016)
Standl, M. et al. Association of atopic dermatitis with cardiometabolic diseases and risk factor. J. Invest. Dermatol. 136, S165-S165 (2016)
Wang, R.* et al. Cellular mechanism of action of IgE-specific immunoadsorption in treatment of patients with severe atopic eczema. J. Invest. Dermatol. 136, S168-S168 (2016)
Wimmer, M. et al. Pollen-derived adenosine plays an important role in induction of ragweed allerg. J. Invest. Dermatol. 136, S229-S229 (2016)
Avitabile, S.* et al. Interleukin-22 promotes wound repair in diabetes by improving keratinocyte pro-healing functions. J. Invest. Dermatol. 135, 2862-2870 (2015)
Baurecht, H.* et al. Epidemiologic and genetic association between atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease, and type-1 diabetes. J. Invest. Dermatol. 135, S63 (2015)
Brosch, S.* et al. Disease control in cutaneous leishmaniasis is independent of IL-22. J. Invest. Dermatol. 135, 308-311 (2015)
Fukunaga-Kalabis, M.* et al. MSX1-induced neural crest-like reprograming promotes melanoma progression. J. Invest. Dermatol. 135, S111 (2015)
Garzorz, N.V.* et al. Molecular diagnostics of psoriasis and eczema-a novel approach to establish personalised therapy. J. Invest. Dermatol. 135, S1 (2015)
Koch, M.* et al. Psoriasis and cardiometabolic traits: Modest association but distinct genetic architectures. J. Invest. Dermatol. 135, 1283-1293 (2015)
Paternoster, L.* ; Standl, M. ; Baurecht, H.* ; Evans, D.M* & Weidinger, S.* Multi-ethnic genome-wide association study of 21,000 cases and 95,000 controls identifies 11 novel risk loci for atopic dermatitis. J. Invest. Dermatol. 135, S56 (2015)
Rodriguez, E.* et al. Targeted resequencing and finemapping identifies functional low-frequency missense variants in LRRC32 as risk factors for atopic dermatitis. J. Invest. Dermatol. 135, S58 (2015)
Garzorz, N.V.* et al. Intra-individual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. J. Invest. Dermatol. 134, S1 (2014)
Kretschmer, A. et al. A common atopy-associated variant in the Th2 cytokine locus control region impacts transcriptional regulation and alters SMAD3 and SP1 binding. J. Invest. Dermatol. 134, S55 (2014)
Röck, K.* et al. miR-23a-3p causes cellular senescence by targeting hyaluronan synthase2: Possible implication for skin aging. J. Invest. Dermatol. 135, 369-377 (2014)
Rodriguez, E.* et al. An integrated epigenetic and transcriptomic analysis reveals distinct tissue-specific patterns of DNA methylation associated with atopic dermatitis. J. Invest. Dermatol. 134, 1873-1883 (2014)
Deo, M.* ; Huang, J. L.-Y.* ; Fuchs, H. ; Hrabě de Angelis, M. & van Raamsdonk, C. D.* Differential effects of neurofibromin gene dosage on melanocyte development. J. Invest. Dermatol. 133, 49-58 (2013)
Sengupta, A.* et al. Targeted disruption of glutathione peroxidase 4 in mouse skin epithelial cells impairs postnatal hair follicle morphogenesis that is partially rescued through inhibition of COX-2. J. Invest. Dermatol. 133, 1731-1741 (2013)
Djafarzadeh, R.* et al. Treatment of dermal fibroblasts with GPI-anchored human TIMP-1 protein moderates processes linked to scar formation. J. Invest. Dermatol. 133, 803-811 (2012)
Ellinghaus, E.* et al. Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. J. Invest. Dermatol. 132, 1133-1140 (2012)
Metz, M.* et al. Evidence for non-allergic mast cell activation in pollen-associated inflammation. J. Invest. Dermatol. 131, 987-990 (2011)
Bergboer, J.G.M.* et al. Deletion of Late Cornified Envelope 3B and 3C genes is not associated with atopic dermatitis. J. Invest. Dermatol. 130, 2057-2061 (2010)
Blume, C. et al. Human epithelial cells of the respiratory tract and the skin differentially internalize grass pollen allergens. J. Invest. Dermatol. 129, 1935-1944 (2009)
Eyerich, K. et al. Patients with Chronic Mucocutaneous Candidiasis Exhibit Reduced Production of Th17-Associated Cytokines IL-17 and IL-22. J. Invest. Dermatol. 128, 2640–2645 (2008)
Novak, N. et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J. Invest. Dermatol. 128, 1430-1435 (2008)
Valet, M.* et al. Cerebral processing of histamine-induced itch using short-term alternating temperature modulation - an FMRI study. J. Invest. Dermatol. 128, 426-433 (2008)
Weidinger, S. et al. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J. Invest. Dermatol. 127, 724-726 (2007)
McGowan, K.A.* ; Fuchs, H. ; Hrabě de Angelis, M. & Barsh, G.S.* Identification of a Keratin 4 mutation in a chemically induced mouse mutant that models white sponge nevus. J. Invest. Dermatol. 127, 60-64 (2006)
McGowan, K.A.* ; Aradhya, S.* ; Fuchs, H. ; Hrabě de Angelis, M. & Barsh, G.S.* A mouse Keratin 1 mutation causes dark skin and epidermolytic hyperkeratosis. J. Invest. Dermatol. 126, 1013-1016 (2006)
Pfab, F.* et al. Short-term alternating temperature enhances histamine-induced itch: A biphasic stimulus model. J. Invest. Dermatol. 126, 2673-2678 (2006)
Schäfer, T.* ; Merkl, J.* ; Klemm, E.* ; Wichmann, H.-E. & Ring, J.* The epidemiology of nevi and signs of skin aging in the adult general population: Results of the KORA-Survey 2000. J. Invest. Dermatol. 126, 1490-1496 (2006)
Krämer, U.* et al. Seasonality in symptom severity influenced by temperature or grass pollen: Results of a panel study children with eczema. J. Invest. Dermatol. 124, 514-523 (2005)
Alessandrini, F. et al. Alterations of glucosylceramide-ß-glucosidase levels in the skin of patients with psoriasis vulgaris. J. Invest. Dermatol. 123, 1030-1036 (2004)
Giehl, K.* et al. A gene locus responsible for the familial hair shaft abnormality pili annulati maps to chromosome 12q24.32-24.33. J. Invest. Dermatol. 123, 1073-1077 (2004)
Mempel, M.* et al. Toll-like receptor expression in human keratinocytes : Nuclear factor kB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J. Invest. Dermatol. 121, 1389-1396 (2003)
Peters, T.H.* et al. Alopecia in a Novel Mouse Model RCO3 Is Caused by mK6irs1 Deficiency. J. Invest. Dermatol. 121, 674-680 (2003)
Schaller, M.* et al. Infection of Human Oral Epithelia with Candida Species Induces Cytokine Expression Correlated to the Degree of Virulence. J. Invest. Dermatol. 118, 652-657 (2002)
Alessandrini, F. ; Stachowitz, S. ; Ring, J.* & Behrendt, H. The Level of Prosaposin is Decreased in the Skin of Patients with Psoriasis Vulgaris. J. Invest. Dermatol. 116, 394-400 (2001)
Darsow, U. et al. Processing of Histamine-Induced Itch in the Human Cerebral Cortex : A Correlation Analysis with Dermal Reactions. J. Invest. Dermatol. 115, 1029-1033 (2000)
Hohenadl, C. et al. Transcriptional Activation of Endogenous Retroviral Sequences in Human Epidermal Keratinocytes by UVB Irradiation. J. Invest. Dermatol. 113, 587-594 (1999)
Mainguy, G.* et al. Regulation of epidermal Bullous Pemphigoid Antigen 1 (BPAG1) synthesis by homeoprotein transcription factors. J. Invest. Dermatol. 113, 643-650 (1999)